跳至主要内容
临床试验/DRKS00041150
DRKS00041150进行中(未招募)不适用

Prospective Multicentre Evaluation of an AI-Based Prostate MRI Analysis Tool for the Detection of Clinically Significant Prostate Cancer Using Histopathology as Reference Standard

Universitätsklinikum Düsseldorf0 个研究点目标入组 240 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(—)
性别
Male

入选标准

  • Consecutive patients with suspected prostate cancer scheduled for prostate mpMRI and potential biopsy according to current guidelines. Patients will be recruited in the department of urology at the different study sites.

排除标准

  • Non-interpretable examinations (PI-QUAL 1).
  • Patients who have undergone surgery or radiotherapy for prostate cancer.
  • Discrepancies and incorrect MR report (filtered out by expert).
  • No signed informed consent.
  • Contraindication for MRI or biopsy.

研究者

相似试验